withanolide d has been researched along with parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer in 1 studies
| Studies (withanolide d) | Trials (withanolide d) | Recent Studies (post-2010) (withanolide d) | Studies (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) | Trials (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) | Recent Studies (post-2010) (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) |
|---|---|---|---|---|---|
| 25 | 0 | 11 | 16 | 0 | 14 |
| Protein | Taxonomy | withanolide d (IC50) | parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.467 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.467 | |
| Transcription factor p65 | Homo sapiens (human) | 0.467 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuendet, M; Freitas Misakyan, MF; Gunatilaka, AAL; Issa, ME; Monteillier, A; Wijeratne, EMK; Xu, YM | 1 |
1 other study(ies) available for withanolide d and parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer
| Article | Year |
|---|---|
Structure-Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Coculture Techniques; Humans; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship; Withania; Withanolides | 2021 |